Tissue Regenix (UK) Performance
| TRX Stock | 38.00 3.50 10.14% |
The entity has a beta of 0.0691, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Tissue Regenix's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tissue Regenix is expected to be smaller as well. At this point, Tissue Regenix Group has a negative expected return of -0.63%. Please make sure to validate Tissue Regenix's rate of daily change, and the relationship between the kurtosis and market facilitation index , to decide if Tissue Regenix Group performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Tissue Regenix Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in May 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
| Begin Period Cash Flow | 5.9 M |
Tissue |
Tissue Regenix Relative Risk vs. Return Landscape
If you would invest 5,850 in Tissue Regenix Group on January 11, 2025 and sell it today you would lose (2,050) from holding Tissue Regenix Group or give up 35.04% of portfolio value over 90 days. Tissue Regenix Group is generating negative expected returns and assumes 2.5225% volatility on return distribution over the 90 days horizon. Simply put, 22% of stocks are less volatile than Tissue, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Tissue Regenix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tissue Regenix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Tissue Regenix Group, and traders can use it to determine the average amount a Tissue Regenix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2497
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TRX |
Estimated Market Risk
| 2.52 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.63 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.25 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Tissue Regenix is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tissue Regenix by adding Tissue Regenix to a well-diversified portfolio.
Tissue Regenix Fundamentals Growth
Tissue Stock prices reflect investors' perceptions of the future prospects and financial health of Tissue Regenix, and Tissue Regenix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tissue Stock performance.
| Return On Equity | -0.0331 | ||||
| Return On Asset | 0.005 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 32.58 M | ||||
| Shares Outstanding | 71.23 M | ||||
| Price To Book | 1.15 X | ||||
| Price To Sales | 0.85 X | ||||
| Revenue | 29.49 M | ||||
| EBITDA | 446 K | ||||
| Total Debt | 9.39 M | ||||
| Book Value Per Share | 0.43 X | ||||
| Cash Flow From Operations | 1.04 M | ||||
| Earnings Per Share | (0.01) X | ||||
| Total Asset | 43.24 M | ||||
| Retained Earnings | (123.76 M) | ||||
About Tissue Regenix Performance
By analyzing Tissue Regenix's fundamental ratios, stakeholders can gain valuable insights into Tissue Regenix's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Tissue Regenix has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Tissue Regenix has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Tissue Regenix Group performance evaluation
Checking the ongoing alerts about Tissue Regenix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Tissue Regenix Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tissue Regenix Group generated a negative expected return over the last 90 days | |
| Tissue Regenix Group has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 29.49 M. Net Loss for the year was (1.71 M) with profit before overhead, payroll, taxes, and interest of 15.73 M. | |
| About 55.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Tissue Regenix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tissue Regenix's stock is overvalued or undervalued compared to its peers.
- Examining Tissue Regenix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tissue Regenix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tissue Regenix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Tissue Regenix's stock. These opinions can provide insight into Tissue Regenix's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Tissue Stock analysis
When running Tissue Regenix's price analysis, check to measure Tissue Regenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tissue Regenix is operating at the current time. Most of Tissue Regenix's value examination focuses on studying past and present price action to predict the probability of Tissue Regenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tissue Regenix's price. Additionally, you may evaluate how the addition of Tissue Regenix to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |